Teva Pharmaceutical Indus... (TEVA)
NYSE: TEVA
· Real-Time Price · USD
17.79
0.25 (1.43%)
At close: Aug 15, 2025, 1:59 PM
Teva Pharmaceutical Industries Fail-to-Deliver
Total FTD Shares
534K
Above Average
FTD / Avg. Volume
4.63%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 11, 2025,
Teva Pharmaceutical Industries Limited has
534,000
shares failed to deliver, representing 4.63%
of the average daily volume of
11,533,807.7
shares. Over the past year, the monthly average FTD is
40,059
shares, with the current level 1233% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 11, 2025 | 16.4 | 534K | +1792.74% |
Jun 23, 2025 | 16.97 | 28.21K | -71.40% |
May 30, 2025 | 16.78 | 98.66K | +395.50% |
Apr 30, 2025 | 15.51 | 19.91K | +421.64% |
Mar 18, 2025 | 16.48 | 3.82K | -95.55% |
Feb 26, 2025 | 16.78 | 85.83K | +428.55% |
Jan 31, 2025 | 17.73 | 16.24K | +1059.93% |
Dec 30, 2024 | 22.32 | 1.4K | +1672.15% |
Nov 20, 2024 | 17.03 | 79 | +7800.00% |
Oct 30, 2024 | 18.59 | 1 | -99.99% |
Sep 30, 2024 | 18.02 | 14.8K | +417.30% |
Aug 29, 2024 | 18.73 | 2.86K | -69.79% |
Jul 30, 2024 | 16.41 | 9.47K | +45000.00% |
Jun 28, 2024 | 16.25 | 21 | -80.73% |
May 30, 2024 | 16.9 | 109 | -93.19% |
Apr 30, 2024 | 14.05 | 1.6K | +6.73% |
Mar 19, 2024 | 13.35 | 1.5K | -66.32% |
Feb 21, 2024 | 13 | 4.45K | +1021.91% |
Jan 31, 2024 | 12.1 | 397 | +98.50% |
Dec 26, 2023 | 10.48 | 200 | -95.44% |
Nov 29, 2023 | 9.69 | 4.39K | +121.78% |
Oct 30, 2023 | 8.55 | 1.98K | -96.17% |
Sep 19, 2023 | 10.29 | 51.65K | +220.31% |
Aug 14, 2023 | 9.55 | 16.12K | +278.23% |
Jul 28, 2023 | 8.56 | 4.26K | -89.27% |
Jun 30, 2023 | 7.53 | 39.72K | +997.24% |
May 31, 2023 | 7.2 | 3.62K | -57.99% |
Apr 26, 2023 | 8.21 | 8.62K | +81.30% |
Mar 30, 2023 | 8.82 | 4.75K | +92.74% |
Feb 23, 2023 | 10.01 | 2.47K | +253.80% |
Jan 27, 2023 | 10.38 | 697 | n/a |